FTC Suing To Stop Amgen’s $27.8 Billion Purchase Of Horizon Therapeutics
Topline
The Federal Trade Commission filed a lawsuit Tuesday to block Amgen Inc. from purchasing Horizon Therapeutics for $27.8 billion, out of concerns the merger would harm patients on Horizon’s two fastest-growing drugs.
FILE - This…